Effects of supplementation in the treatment of diabetic foot

Phase 3

• Conditions: Diabetic foot.; With peripheral circulatory complications; E14.5

• Registration Number: IRCT201506215623N46
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with diabetic foot according to Wagner criteria higher than 5 years of their disease; aged 40 to 85 years

Exclusion Criteria

The use of substitute treatments including hormone or vitamin or zinc supplements
Patients with chronic kidney disease, liver, lung, chronic or acute inflammatory diseases, heart valve disease, short bowel syndrome and allergies
Patients with low immune system ability (autoimmune)
Pregnant
Lactating

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Calculation using HOMA formula.;Healing of diabetic foot ulcer. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Decrease of the wound size relative to original size: ulcer length (cm), ulcer width (cm), Ulcer depth (cm).